BANK OF AMERICA CORP /DE/ - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 69 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$14,970
-57.4%
31,9200.0%0.00%
Q2 2023$35,112
-7.6%
31,9200.0%0.00%
Q1 2023$37,985
+14126.6%
31,920
+17732.4%
0.00%
Q4 2022$267
-86.6%
179
-87.0%
0.00%
Q3 2022$2,0000.0%1,3780.0%0.00%
Q2 2022$2,0000.0%1,3780.0%0.00%
Q1 2022$2,000
-33.3%
1,378
-21.8%
0.00%
Q4 2021$3,000
+50.0%
1,762
+75.5%
0.00%
Q3 2021$2,0000.0%1,004
+42.8%
0.00%
Q2 2021$2,000
-95.7%
703
-95.7%
0.00%
Q1 2021$46,000
+100.0%
16,305
+96.3%
0.00%
Q4 2020$23,000
+53.3%
8,305
+17.0%
0.00%
Q3 2020$15,000
-70.0%
7,101
-36.1%
0.00%
Q2 2020$50,000
-51.9%
11,112
-12.5%
0.00%
Q1 2020$104,000
-54.0%
12,702
+3.2%
0.00%
Q4 2019$226,000
+66.2%
12,314
-0.1%
0.00%
Q3 2019$136,000
-1.4%
12,322
-9.3%
0.00%
Q2 2019$138,000
+2.2%
13,582
-41.2%
0.00%
Q1 2019$135,000
-30.1%
23,094
-15.0%
0.00%
Q4 2018$193,000
+206.3%
27,182
+210.4%
0.00%
Q3 2018$63,000
+133.3%
8,758
+60.1%
0.00%
Q2 2018$27,000
+107.7%
5,470
+337.6%
0.00%
Q1 2018$13,000
-35.0%
1,250
-40.3%
0.00%
Q4 2017$20,000
-96.0%
2,095
-96.2%
0.00%
Q3 2017$501,000
+30.1%
55,745
+1.7%
0.00%
Q2 2017$385,000
+38400.0%
54,835
+43077.2%
0.00%
Q1 2017$1,0000.0%127
+62.8%
0.00%
Q4 2016$1,00078
+41.8%
0.00%
Q2 2016$0550.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders